NO | Mga produkto | Cas no | Application | Pangunahing tagapagpahiwatig ng kalidad | ||||
Kadalisayan | Isomer | Tiyak na karumihan | *Max1 | Kahalumigmigan | ||||
1 | FMOC-CYS (ACM) -OH | 86060-81-3 | Disulfide Bond | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
2 | FMOC-CYS (MMT) -OH | 177582-21-7 | Disulfide Bond | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
3 | Fmoc-cys (4-allylbutyrate) -OH | / | Disulfide Bond | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
4 | MPa (trt) -Oh | 27144-18-9 | Pagtatapos ng pagkakasunud -sunod | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
5 | Fmoc-thr (tbu) -ol | 189337-28-8 | Octreotide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | FMOC-D-ARG (PBF) -OH | 187618-60-6 | Desmopressin | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
7 | Fmoc-gly-gly-oh | 35665-38-4 | Bivalirudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
8 | Fmoc-gly-gly-gly-oh | 170941-79-4 | Terlipressin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
9 | Fmoc-gly-gly-gly-gly-oh | / | Bivalirudin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
10 | Fmoc-gly-asp (TBU) -OH | / | Bivalirudin | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
11 | BOC-CYS (TRT) -OH | 21947-98-8 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
12 | BOC-ARG (PBF) -OH | 200124-22-7 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
13 | BOC-ALA-OH | 15761-38-3 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
14 | BOC-D-PHE-OH | 18942-49-9 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
15 | Boc-gly-oh | 4530-20-5 | Pagtatapos ng pagkakasunud -sunod | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
16 | Boc-lys (BOC) -OH.dcha | 15098-69-8 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
17 | BOC-SER (TBU) -OH | 7738-22-9 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
18 | BOC-Thr (TBU) -OH | 13734-40-2 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
19 | BOC-D-ALA-OH | 7764-95-6 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
20 | Boc-Met-Oh | 2488-15-5 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
21 | BOC-Tyr (TBU) -OH | 47375-34-8 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
22 | BOC-D-ARG (PDF) -OH | 187618-60-6 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
23 | Boc-asp (otbu) -oh.dcha | 1913/12/8 | Pagtatapos ng pagkakasunud -sunod | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
24 | Fmoc-homoarg (PBF) -OH | 1159680-21-3 | Eptifibatide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
25 | Fmoc-asp-otbu | 129460-09-9 | Thymalfasin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
26 | Fmoc-tyr (ako) -oh | 77128-72-4 | Carbetocin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
27 | Fmoc-orn (BOC) -OH | 109425-55-0 | Atosiban Omnipressin Daptomycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
28 | FMOC-D-TYR (ET) -OH | 162502-65-0 | Atosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
29 | Fmoc-asp (oall) -OH | 146982-24-3 | Melanotan | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
30 | AC-NLE-OH | 15891-49-3 | Melanotan | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
31 | Fmoc-nle-oh | 77284-32-3 | Melanotan Afamelanotide | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
32 | Ac-glu (otbu) -Oh | 84192-88-1 | Argireline Acetyl octapeptide-3 | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
33 | Ac-β-ala-oh · dcha | / | Acetyl tetrapeptide-5 | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
34 | Fmoc-ß-ala-oh | 35737-10-1 | Acetyl tetrapeptide-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
35 | Fmoc-hyp (tbu) -Oh | 122996-47-8 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
36 | Fmoc-thi-oh | 130309-35-2 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
37 | Fmoc-d-tic-oh | 130309-33-0 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
38 | Fmoc-oic-oh | 130309-37-4 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
39 | Boc-Sar-Oh | 13734-36-6 | Saralikin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
40 | Fmoc-sar-oh | 77128-70-2 | Saralikin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
41 | Fmoc-tyr (SO3NA) -OH.H2O | 106864-37-3 | Sincalide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
42 | Fmoc-d-asp (OTBU) -OH | 112883-39-3 | Daptomycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
43 | AC-SER (TBU) -OH | 77285-09-7 | Afamelanotide | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
44 | BOC-HOMOCYS (TRT) -OH | 201419-16-1 | Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
45 | FMOC-HOMOCYS (TRT) -OH | 167015-23-8 | Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
46 | Fmoc-dab-oh | 161420-87-7 | Snake Venom | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
*Max1 = max hindi kilalang kadalisayan
Iba pang tagapagpahiwatig:
- acetic acid: ≤0.02% (lahat ng mga produkto)
- Ethyl Acetate: ≤0.5% (lahat ng mga produkto)
- Alkohol: ≤0.5% (lahat ng mga produkto)
-max hindi alam na karumihan: FMOC-TRP (BOC) -OH (143824-78-6) ≤0.3%; Ang iba ≤0.2%